Director of Interventional Vascular Surgery; Director of diabetes Foot Clinic; Chief physician; Associate Professor; Doctor of Medicine; Doctoral supervisor; Visiting Scholar at Beth Israel Deaconess Medical Center, Harvard Medical School, USA; Visiting scholar at Bard Krozingen Cardiovascular Treatment Center, University of Freiburg, Germany; At present, more than 30 SCI and core journal articles have been published, responsible for 1 national level project and 4 provincial-level scientific research projects in Guangdong.

(1) From September 2012 to June 2016, Jinan University, Department of Imaging and Nuclear Medicine, Doctoral Degree

(2) From September 2008 to June 2011, Jinan University, Medical Imaging and Nuclear Medicine, Master's Degree

(3) From September 2003 to June 2008, North China University of Science and Technology, Medical School, Medical Imaging, Bachelor's Degree

(1) From June 2025 to present, Jinan University, First Clinical Medical College, Chief Physician

(2) From October 2019 to May 2025, Jinan University, First Clinical Medical College, served as a Deputy Chief Physician

(3) From October 2014 to September 2019, Jinan University, First Clinical Medical College, Attending Physician

(4) From August 2017 to September 2017, University of Freiburg, Medical School, No

(5) From June 2017 to July 2017, Harvard University, School of Medicine, no specific position/role provided

(6) From August 2011 to September 2014, Jinan University, First Clinical Medical College, Physician

[1]   Zhao, Y, Wu Y, Lin K, Yang B, Deng X, Lu C, Chen Y, and Li C, Effectiveness and Safety of TRIPLET Protocol in Patients with Intermediate-Stage Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization Refractory. Acad Radiol[J], 2025. DOI: 10.1016/j.acra.2025.05.013.

[2]   Liu, W, Wei R, Chen J, Li Y, Pang H, Zhang W, An C, and Li C, Prognosis prediction and risk stratification of transarterial chemoembolization or intraarterial chemotherapy for unresectable hepatocellular carcinoma based on machine learning. Eur Radiol[J], 2024, 34(8):5094-5107. DOI: 10.1007/s00330-024-10581-2.

[3]   Li, Y, Liu W, Chen J, Chen Y, Guo J, Pang H, Zhang W, An C, and Li C, Efficiency and safety of hepatic arterial infusion chemotherapy (HAIC) combined with anti-PD1 therapy versus HAIC monotherapy for advanced hepatocellular carcinoma: A multicenter propensity score matching analysis. Cancer Med[J], 2024, 13(1):e6836. DOI: 10.1002/cam4.6836.

[4]   Li, Y, Guo J, Liu W, Pang H, Song Y, Wu S, Zhang F, Yan D, Chen J, An C, and Li C, Hepatic artery infusion chemotherapy combined with camrelizumab plus rivoceranib for hepatocellular carcinoma with portal vein tumor thrombosis: a multicenter propensity score-matching analysis. Hepatol Int[J], 2024, 18(4):1286-1298. DOI: 10.1007/s12072-024-10672-8.

[5]   He, X, Li K, Wei R, Zuo M, Yao W, Zheng Z, He X, Fu Y, Li C, An C, and Liu W, Correction: A multitask deep learning radiomics model for predicting the macrotrabecular‑massive subtype and prognosis of hepatocellular carcinoma after hepatic arterial infusion chemotherapy. Radiol Med[J], 2024, 129(2):350-351. DOI: 10.1007/s11547-023-01754-y.

[6]   Long, F, Chen S, Li R, Lin Y, Han J, Guo J, Chen Y, Li C, and Song P, Efficacy and safety of HAIC alone vs. HAIC combined with lenvatinib for treatment of advanced hepatocellular carcinoma. Med Oncol[J], 2023, 40(5):147. DOI: 10.1007/s12032-023-02012-x.

[7]   Liu, Y, Qiao Y, Zhou M, Guo J, Lin Y, Li W, An C, and Li C, Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and sequential ablation in the treatment of advanced hepatocellular carcinoma. Cancer Med[J], 2023, 12(5):5436-5449. DOI: 10.1002/cam4.5366.

[8]   Li, W, Wang L, Zhang Y, Liu Y, Lin Y, and Li C, A SEER data-based nomogram for the prognostic analysis of survival of patients with Kaposi's sarcoma. J Cancer Res Ther[J], 2023, 19(4):917-923. DOI: 10.4103/jcrt.jcrt_2587_22.

[9]   Li, W, Chen M, Zhang Y, Zhang H, and Li C, A Clinical Series in Patients with Naso-Pharyngeal Cancer and Their Outcomes with Stent Graft Treatment for Sentinel Bleeding to Prevent Frank Carotid Rupture. Ann Vasc Surg[J], 2023, 92:111-117. DOI: 10.1016/j.avsg.2022.12.086.

[10]   He, X, Li K, Wei R, Zuo M, Yao W, Zheng Z, He X, Fu Y, Li C, An C, and Liu W, A multitask deep learning radiomics model for predicting the macrotrabecular-massive subtype and prognosis of hepatocellular carcinoma after hepatic arterial infusion chemotherapy. Radiol Med[J], 2023, 128(12):1508-1520. DOI: 10.1007/s11547-023-01719-1.

[11]   Chen, C, Han Q, Ren H, Wu S, Li Y, Guo J, Li X, Liu X, Li C, and Tian Y, Multiparametric MRI-based model for prediction of local progression of hepatocellular carcinoma after thermal ablation. Cancer Med[J], 2023, 12(17):17529-17540. DOI: 10.1002/cam4.6277.

[12]   You, H, Liu X, Guo J, Lin Y, Zhang Y, and Li C, Hepatic arterial infusion chemotherapy and sequential ablation treatment in large hepatocellular carcinoma. Int J Hyperthermia[J], 2022, 39(1):1097-1105. DOI: 10.1080/02656736.2022.2112307.

[13]   Li, W, You H, Zhang Y, Zhang H, and Li C, 2D perfusion angiography: an alternative method to evaluate endovascular intervention for acute lower limb ischemia. BMC Cardiovasc Disord[J], 2022, 22(1):522. DOI: 10.1186/s12872-022-02979-x.

[14]   Li, C, You H, Zhang H, Liu Y, Li W, Wang X, and Zhang Y, Application of relay puncture technique in treating patients with complicated lower extremity arterial diseases. PeerJ[J], 2019, 7:e6345. DOI: 10.7717/peerj.6345.

[15]   Li, C, Liu X, You H, Zhang H, Liu Y, and Zhang Y, Perfusion imaging with 320-slice spiral computed tomography and color-coded digital subtraction angiography for assessing acute skeletal muscle ischemia-reperfusion injury in a rabbit model. BMC Med Imaging[J], 2019, 19(1):75. DOI: 10.1186/s12880-019-0353-1.

1) Research on Fiber Optic Sensing Technology for Tumor Microenvironment Markers in Physical Examination and Diagnosis, 2023.08, 623300012, National Level, 3.4 million, Main Participants 

2) Clinical study on AI based 2D perfusion imaging parameters of lower limb arteries for assisting decision-making of intervention strategies in patients with acute lower limb ischemia, July 2023, provincial and ministerial level, 400000, first person in charge 

3) Research on the New Talent Training Model under the Medical Engineering Alliance, July 24, 2023, Provincial and Ministerial Level, First Responsible Person 

4) Impact of blood pressure census on prevention and control of incidence rate of aortic dissection in rural areas, 2019-05-28, 2019SKJ026, provincial and ministerial level, 100000, the first person in charge 

5) Related research on real-time evaluation of limb ischemia-reperfusion injury during angiography machine surgery, September 11, 2017, 21617318, school level, 150000, first person in charge 

6) Magnetic Resonance H-Proton Pop up Study on Acute Ischemic Rhabdoid Muscle Lysis, October 1, 2015, 2014A020212728, Provincial and Ministerial Level, 50000, Second Leader 

7) Clinical application research of new intracavitary treatment technology in lower limb ischemic diseases, May 1, 2015, 2014A020209038, provincial and ministerial level, 50000, second person in charge

Li Chengzhi; Painted; Zeng Yi. A vascular support catheter with rotational cutting. Chinese invention patent: ZL 201810868210.0.

Currently serving as a standing committee member of the Liver Cancer Integration Committee of the China Anti Cancer Association, vice chairman of the Interventional Diagnosis and Treatment Branch of the Guangdong Hospital Management Society, vice chairman of the Precision Intervention Branch of the Guangdong Precision Medicine Application Society, vice chairman of the Vascular Disease Committee of the Guangdong Health Management Society, vice chairman of the Vascular Surgery Branch of the Guangzhou Medical Association, standing committee member and secretary-general of the Peripheral Vascular Disease Branch of the Guangdong Precision Medicine Application Society, standing committee member of the Interventional Branch of the Guangdong Medical Association, standing committee member of the Vascular Surgery Committee of the Guangdong Medical Association, standing committee member of the Vascular Surgery Professional Committee of the Guangdong Clinical Medicine Society, and standing committee member of the Vascular Disease Diagnosis and Treatment Committee of the Guangdong Hospital Management Society.